Difficulty: Medium
Average Score: 77%
Practice
In the treatment of hypothyroidism, thyroxine is preferred over liothyronine because thyroxine
Correct answer
B
Rationale
In the treatment of hypothyroidism, thyroxine is preferred over liothyronine because thyroxine has a longer half-life. This is the correct answer (B) because thyroxine, also known as T4, has a half-life of around 7 days compared to liothyronine, also known as T3, which has a half-life of around 1 day. This longer half-life of thyroxine allows for a more stable and sustained level of thyroid hormone in the body, leading to better symptom control and reduced frequency of dosing.
Option A, that thyroxine can be made more easily by recombinant DNA technology, is incorrect as the ease of production does not necessarily dictate its preference in treatment. Option C, stating that thyroxine has higher affinity for thyroid hormone receptors, is also incorrect as both thyroxine and liothyronine have similar affinities for thyroid hormone receptors. Option D, suggesting that thyroxine is faster acting, is incorrect as liothyronine is actually the faster-acting form of thyroid hormone.
In an educational context, understanding the pharmacological differences between thyroxine and liothyronine is important for healthcare professionals managing patients with hypothyroidism. Knowing why thyroxine is preferred can help guide treatment decisions and optimize patient outcomes. It also highlights the importance of considering pharmacokinetics and pharmacodynamics when selecting appropriate medications for thyroid disorders.
Option A, that thyroxine can be made more easily by recombinant DNA technology, is incorrect as the ease of production does not necessarily dictate its preference in treatment. Option C, stating that thyroxine has higher affinity for thyroid hormone receptors, is also incorrect as both thyroxine and liothyronine have similar affinities for thyroid hormone receptors. Option D, suggesting that thyroxine is faster acting, is incorrect as liothyronine is actually the faster-acting form of thyroid hormone.
In an educational context, understanding the pharmacological differences between thyroxine and liothyronine is important for healthcare professionals managing patients with hypothyroidism. Knowing why thyroxine is preferred can help guide treatment decisions and optimize patient outcomes. It also highlights the importance of considering pharmacokinetics and pharmacodynamics when selecting appropriate medications for thyroid disorders.